The protocol during thrombolytic therapy provides for the execution of a control CT scan to determine if there is the occurrence of cerebral bleeding as a side effect.

This examination is usually done after 24 hours. TES^®, on the other hand, allows to monitor the patient at any moment following the start of thrombolytic therapy, allowing constant monitoring.

This makes the therapy much safer and allows timely intervention to stem any bleeding without delay and without subjecting the patient to further harmful examinations with ionizing radiation.

In fact, the TES^® technology is absolutely harmless and can be used repeatedly.